Cell free DNA testing at 9 weeks: A clinical laboratory experience

Maternal fragile sites resulting in maternal mosaic deletions: an additional explanation for false positive cell-free DNA

Updated clinical experience with esoteric aneuploidies on a genome-wide cell-free DNA test

Cause for clinical concern: genome-wide cfDNA for cases screening positive for trisomy 15

Clinical outcomes of genome-wide cell-free DNA (cfDNA) for cases screening positive for trisomy 9